All Articles tagged biosimilar
Gastrointestinal Conditions
November 20, 2023 EDT This study describes persistence and dose titration among patients with Crohn's disease with 3 years of follow-up. Patients initiating ustekinumab had the highest persistence rate and lowest dose escalation rate.
Methodology and Healthcare Policy
February 03, 2022 EDT The purpose of this study is to investigate the impact of generic/biosimilar entry on drug budgets in different country settings.